Lord, Abbett & Co
SGYP

Lord, Abbett & Co’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Lord, Abbett & Co’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-335,000
Closed -$1.56M – 960
2017
Q1 		$1.56M Hold
335,000
– – ﹤0.01% 847
2016
Q4 		$2.04M Buy
+335,000
New +$1.75M 0.01% 831
2016
Q1 		– Sell
-714,132
Closed -$4.05M – 988
2015
Q4 		$4.05M Sell
714,132
-169,114
-19% -$1.03M 0.01% 775
2015
Q3 		$4.68M Sell
883,246
-129,642
-13% -$1M 0.01% 756
2015
Q2 		$8.41M Buy
+1,012,888
New +$4.91M 0.02% 672

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return